Valuation IRLAB Therapeutics AB

Stocks

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 12/06/2026 BST			5-day change	1st Jan Change
1.242 ^SEK	-2.05%		-2.05%	-36.95%

06-08	Irlab shares trade ex-rights on Nasdaq Stockholm following rights issue	FW
06-05	IRLAB Therapeutics AB Announces Board Elections, Effective June 5, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Market Cap ¹	2,173	2,277	1,987	389	557.6	105.5	105.5	-
Change	-	4.76%	-12.75%	-80.42%	43.33%	-81.08%	0%	-
Enterprise Value (EV)	2,173	1,875	1,734	277.7	494.2	105.5	105.5	105.5
Change	-	-13.73%	-7.53%	-83.98%	77.96%	-78.65%	0%	0%
P/E Ratio	-21.9x	44x	-17.5x	-2.19x	-6.72x	-	-	-
PBR	-	-	6.83x	-	17.1x	-	-	-
PEG	-	-0x	0x	-0x	0.1x	-	-	-
Capitalization / Revenue	-	11x	32.5x	68.5x	5.89x	2.91x	1.03x	0.74x
EV / Revenue	-	0x	0x	0x	0x	1.87x	1.03x	0.74x
EV / EBITDA	-	0x	-0x	-0x	-0x	-1.19x	-3.82x	2.83x
EV / EBIT	-	0x	-0x	-0x	-0x	-1.13x	-3.34x	3.17x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.92	1	-2.19	-3.43	-1.6	-	-	-
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	207.8	61.14	5.678	94.63	57.46	102	141.8
EBITDA ¹	-	56.05	-108.3	-176.4	-70.53	-89.08	-27.6	37.3
EBIT ¹	-	52.58	-113.1	-180.8	-75.11	-93.4	-31.6	33.3
Net income ¹	-91.65	51.78	-113.4	-177.8	-83.13	-110	-32.6	33.3
Net Debt	-	-401.9	-252.8	-111.3	-63.38	-	-	-
Reference price ²	42.000	44.000	38.300	7.500	10.750	1.242	1.242	1.242
Nbr of stocks (in thousands)	51,748	51,748	51,868	51,868	51,868	84,938	84,938	-
Announcement Date	15/04/21	23/02/22	23/02/23	07/02/24	12/02/25	25/02/26	-	-

¹SEK in Million²SEK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IRLAB THERAPEUTICS AB	-	-	-	-	11.23M
ELI LILLY AND COMPANY	33.15x	12.05x	24.81x	0.6%	1,010B
JOHNSON & JOHNSON	25.74x	5.93x	16.13x	2.22%	580B
ABBVIE INC.	27.88x	6.79x	13.86x	3.01%	402B
ROCHE HOLDING AG	17.71x	4.37x	10.73x	3.04%	330B
NOVARTIS AG	21.24x	5.49x	13.32x	2.92%	281B
ASTRAZENECA PLC	22.78x	4.74x	13.47x	1.85%	280B
NOVO NORDISK A/S	12.7x	4.76x	9.73x	3.95%	197B
AMGEN INC.	23.09x	6.16x	10.76x	2.84%	192B
GILEAD SCIENCES, INC.	-45x	5.43x	29.95x	2.58%	156B
Average	15.48x	6.19x	15.86x	2.56%	342.89B
Weighted average by Cap.	22.68x	7.47x	17.41x	2.09%